title: [Malignant mixed müllerian tumor of the uterus following tamoxifen for breast cancer: case report].
abstract: Tamoxifen is an antioestrogen widely used in the breast cancer treatment. Its paradoxical antioestrogenic action on breast and its oestrogenic action on the endometer is well-known. Since 1988, few cases of malignant mixed müllerian tumors following tamoxifen were described. We report a new case of uterine malignant mixed müllerian tumor four years after the end of tamoxifen for breast cancer.
authors.affiliation: Service de gynécologie-obstétrique, hôpital Lariboisière, Assistance publique des Hôpitaux de Paris (AP-HP), 2, rue Ambroise-Paré, 75010 Paris, France.
authors.forename: M
authors.initials: M
authors.lastname: Saim
authors.affiliation: Service d'anatomie pathologique, hôpital Lariboisière, Assistance publique des Hôpitaux de Paris (AP-HP), 2, rue Ambroise-Paré, 75010 Paris, France.
authors.forename: J-F
authors.initials: JF
authors.lastname: Cote
authors.affiliation: Service de gynécologie-obstétrique, hôpital Lariboisière, Assistance publique des Hôpitaux de Paris (AP-HP), 2, rue Ambroise-Paré, 75010 Paris, France.
authors.forename: O
authors.initials: O
authors.lastname: Morel
authors.affiliation: Service de gynécologie-obstétrique, hôpital Lariboisière, Assistance publique des Hôpitaux de Paris (AP-HP), 2, rue Ambroise-Paré, 75010 Paris, France.
authors.forename: C
authors.initials: C
authors.lastname: Malartic
authors.affiliation: Service de gynécologie-obstétrique, hôpital Lariboisière, Assistance publique des Hôpitaux de Paris (AP-HP), 2, rue Ambroise-Paré, 75010 Paris, France.
authors.forename: G
authors.initials: G
authors.lastname: Akerman
authors.affiliation: Service d'anatomie pathologique, hôpital Lariboisière, Assistance publique des Hôpitaux de Paris (AP-HP), 2, rue Ambroise-Paré, 75010 Paris, France.
authors.forename: F
authors.initials: F
authors.lastname: Gray
authors.affiliation: Service de gynécologie-obstétrique, hôpital Lariboisière, Assistance publique des Hôpitaux de Paris (AP-HP), 2, rue Ambroise-Paré, 75010 Paris, France. Electronic address: ebarrang@club-internet.fr.
authors.forename: E
authors.initials: E
authors.lastname: Barranger
mesh_terms: D000369:Aged, 80 and over; D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects* / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D018200:Mixed Tumor, Mullerian / Q000139:chemically induced* / Q000473:pathology; D013629:Tamoxifen / Q000009:adverse effects* / Q000627:therapeutic use; D014594:Uterine Neoplasms / Q000139:chemically induced* / Q000473:pathology
chemical_list: D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen